Holds one active US DMF and 2 valid CEPs for warfarin, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds one active US DMF and 2 valid CEPs for warfarin, filing since 2008. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 19 markets.
Holds 2 active US DMFs and 2 valid CEPs for warfarin, filing since 2011. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 18 markets.
Holds one active US DMF for warfarin, filing since 1998. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds one active US DMF for warfarin, filing since 2009. Its 2025 FDA inspection closed as NAI.
Holds 2 active US DMFs for warfarin, filing since 2008. Its 2019 FDA inspection closed as VAI.
Holds one active US DMF for warfarin, filing since 2008. Its 2025 FDA inspection closed as OAI.
Registered with SFDA (Saudi Arabia) for warfarin.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
This page filters the worldwide Warfarin manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free